1. AustrianR (1986) Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 18 Suppl A: 35–45.
2. HogbergL, GeliP, RingbergH, MelanderE, LipsitchM, et al. (2007) Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol 45: 948–952.
3. MusherDM (1992) Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 14: 801–807.
4. O'BrienKL, WolfsonLJ, WattJP, HenkleE, Deloria-KnollM, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893–902.
5. McCullersJA, TuomanenEI (2001) Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 6: D877–889.
6. PallaresR, LinaresJ, VadilloM, CabellosC, ManresaF, et al. (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333: 474–480.
7. SchuchatA, RobinsonK, WengerJD, HarrisonLH, FarleyM, et al. (1997) Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 337: 970–976.
8. Mook-KanamoriBB, GeldhoffM, van der PollT, van de BeekD (2011) Pathogenesis and pathophysiology of pneumococcal meningitis. Clinical Microbiology Reviews 24: 557–591.
9. CundellDR, GerardNP, GerardC, Idanpaan-HeikkilaI, TuomanenEI (1995) Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435–438.
10. Le GouillC, ParentJL, Rola-PleszczynskiM, StankovaJ (1997) Structural and functional requirements for agonist-induced internalization of the human platelet-activating factor receptor. J Biol Chem 272: 21289–21295.
11. RadinJN, OrihuelaCJ, MurtiG, GuglielmoC, MurrayPJ, et al. (2005) beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infection and Immunity 73: 7827–7835.
12. RijneveldAW, WeijerS, FlorquinS, SpeelmanP, ShimizuT, et al. (2004) Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. Journal of Infectious Diseases 189: 711–716.
13. ClarkeTB, FrancellaN, HuegelA, WeiserJN (2011) Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe 9: 404–414.
14. AttaliC, DurmortC, VernetT, Di GuilmiAM (2008) The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infection and Immunity 76: 5350–5356.
15. KolumamGA, ThomasS, ThompsonLJ, SprentJ, Murali-KrishnaK (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637–650.
16. ToughDF, BorrowP, SprentJ (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947–1950.
17. ChoHJ, HayashiT, DattaSK, TakabayashiK, Van UdenJH, et al. (2002) IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol 168: 4907–4913.
18. AlsharifiM, LobigsM, RegnerM, LeeE, KoskinenA, et al. (2005) Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection. J Immunol 175: 4635–4640.
19. TheofilopoulosAN, BaccalaR, BeutlerB, KonoDH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23: 307–336.
20. PestkaS, KrauseCD, WalterMR (2004) Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202: 8–32.
21. AggarwalBB, PanditaR (1994) Both type I and type II interferons down-regulate human tumor necrosis factor receptors in human hepatocellular carcinoma cell line Hep G2. Role of protein kinase C. FEBS Lett 337: 99–102.
22. GuardaG, BraunM, StaehliF, TardivelA, MattmannC, et al. (2011) Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213–223.
23. JoyceEA, PopperSJ, FalkowS (2009) Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression. BMC Genomics 10: 404.
24. ParkerD, MartinFJ, SoongG, HarfenistBS, AguilarJL, et al. (2011) Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio 2: e00016–00011.
25. NakamuraS, DavisKM, WeiserJN (2011) Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. Journal of Clinical Investigation 121: 3657–3665.
26. MancusoG, MidiriA, BiondoC, BeninatiC, ZummoS, et al. (2007) Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 178: 3126–3133.
27. KoppeU, HognerK, DoehnJM, MullerHC, WitzenrathM, et al. (2012) Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs. Journal of Immunology 188: 811–817.
28. OrihuelaCJ, GaoG, McGeeM, YuJ, FrancisKP, et al. (2003) Organ-specific models of Streptococcus pneumoniae disease. Scand J Infect Dis 35: 647–652.
29. BeisswengerC, CoyneCB, ShchepetovM, WeiserJN (2007) Role of p38 MAP kinase and transforming growth factor-beta signaling in transepithelial migration of invasive bacterial pathogens. J Biol Chem 282: 28700–28708.
30. TalbotUM, PatonAW, PatonJC (1996) Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infection and Immunity 64: 3772–3777.
31. SunSC, GanchiPA, BallardDW, GreeneWC (1993) NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259: 1912–1915.
32. BrownK, ParkS, KannoT, FranzosoG, SiebenlistU (1993) Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci U S A 90: 2532–2536.
33. ScottML, FujitaT, LiouHC, NolanGP, BaltimoreD (1993) The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev 7: 1266–1276.
34. ShivshankarP, SanchezC, RoseLF, OrihuelaCJ (2009) The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells. Molecular Microbiology 73: 663–679.
35. OrihuelaCJ, MahdaviJ, ThorntonJ, MannB, WooldridgeKG, et al. (2009) Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. Journal of Clinical Investigation 119: 1638–1646.
36. VossS, HallstromT, SalehM, BurchhardtG, PribylT, et al. (2013) The Choline-binding Protein PspC of Streptococcus pneumoniae Interacts with the C-terminal Heparin-binding Domain of Vitronectin. Journal of Biological Chemistry 288: 15614–15627.
37. AgarwalV, AsmatTM, LuoS, JenschI, ZipfelPF, et al. (2010) Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. Journal of Biological Chemistry 285: 23486–23495.
38. HammerschmidtS, AgarwalV, KunertA, HaelbichS, SkerkaC, et al. (2007) The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. Journal of Immunology 178: 5848–5858.
39. QuinLR, OnwubikoC, MooreQC, MillsMF, McDanielLS, et al. (2007) Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo. Infection and Immunity 75: 4082–4087.
40. WagnerC, KhanAS, KamphausenT, SchmausserB, UnalC, et al. (2007) Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix. Cell Microbiol 9: 450–462.
41. AttaliC, DurmortC, VernetT, Di GuilmiAM (2008) The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect Immun 76: 5350–5356.
42. SpeshockJL, Doyon-RealeN, RabahR, NeelyMN, RobertsPC (2007) Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun 75: 3102–3111.
43. KlugmanKP, ChienYW, MadhiSA (2009) Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 27 Suppl 3: C9–C14.
44. O'BrienKL, WaltersMI, SellmanJ, QuinliskP, RegneryH, et al. (2000) Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30: 784–789.
45. StensballeLG, HjulerT, AndersenA, KaltoftM, RavnH, et al. (2008) Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study. Clin Infect Dis 46: 1165–1171.
46. KrausJ, LingAK, HammS, VoigtK, OschmannP, et al. (2004) Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Annals of Neurology 56: 192–205.
47. MinagarA, LongA, MaT, JacksonTH, KelleyRE, et al. (2003) Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 10: 299–307.
48. KurugantiPA, HinojozaJR, EatonMJ, EhmannUK, SobelRA (2002) Interferon-beta counteracts inflammatory mediator-induced effects on brain endothelial cell tight junction molecules-implications for multiple sclerosis. Journal of Neuropathology and Experimental Neurology 61: 710–724.
49. KatakuraK, LeeJ, RachmilewitzD, LiG, EckmannL, et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115: 695–702.
50. Vijay-KumarM, WuH, AitkenJ, KolachalaVL, NeishAS, et al. (2007) Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis 13: 856–864.
51. BukholmG, BerdalBP, HaugC, DegreM (1984) Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect Immun 45: 62–66.
52. NieselDW, HessCB, ChoYJ, KlimpelKD, KlimpelGR (1986) Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. Infect Immun 52: 828–833.
53. WeigentDA, HuffTL, PetersonJW, StantonGJ, BaronS (1986) Role of interferon in streptococcal infection in the mouse. Microb Pathog 1: 399–407.
54. ShahangianA, ChowEK, TianX, KangJR, GhaffariA, et al. (2009) Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 119: 1910–1920.
55. KnappS, LeemansJC, FlorquinS, BrangerJ, MarisNA, et al. (2003) Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. American Journal of Respiratory and Critical Care Medicine 167: 171–179.
56. FillonS, SoulisK, RajasekaranS, Benedict-HamiltonH, RadinJN, et al. (2006) Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J Immunol 177: 6182–6191.
57. KeelyS, GloverLE, WeissmuellerT, MacManusCF, FillonS, et al. (2010) Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia. Mol Biol Cell 21: 538–546.
58. PrescottSM, ZimmermanGA, StafforiniDM, McIntyreTM (2000) Platelet-activating factor and related lipid mediators. Annual Review of Biochemistry 69: 419–445.
59. EdwardsLJ, ConstantinescuCS (2009) Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases. Inflamm Allergy Drug Targets 8: 182–190.
60. TsouprasAB, IatrouC, FrangiaC, DemopoulosCA (2009) The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Infect Disord Drug Targets 9: 390–399.
61. HsuehW, CaplanMS, SunX, TanX, MacKendrickW, et al. (1994) Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. Acta Paediatr Suppl 396: 11–17.
62. XuLF, TengX, GuoJ, SunM (2012) Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation 35: 308–315.
63. McCullersJA, IversonAR, McKeonR, MurrayPJ (2008) The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scandinavian Journal of Infectious Diseases 40: 11–17.
64. LacksS, HotchkissRD (1960) A study of the genetic material determining an enzyme in Pneumococcus. Biochim Biophys Acta 39: 508–518.
65. BlasigIE, GieseH, SchroeterML, SporbertA, UtepbergenovDI, et al. (2001) *NO and oxyradical metabolism in new cell lines of rat brain capillary endothelial cells forming the blood-brain barrier. Microvasc Res 62: 114–127.
66. MullerU, SteinhoffU, ReisLF, HemmiS, PavlovicJ, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918–1921.
67. MausUA, SrivastavaM, PatonJC, MackM, EverhartMB, et al. (2004) Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. Journal of Immunology 173: 1307–1312.
68. TalbotUM, PatonAW, PatonJC (1996) Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect Immun 64: 3772–3777.
69. GriggJ, WaltersH, SohalSS, Wood-BakerR, ReidDW, et al. (2012) Cigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cells. Thorax 67: 908–913.
70. van der SluijsKF, van EldenLJ, NijhuisM, SchuurmanR, FlorquinS, et al. (2006) Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol 290: L194–199.
71. SheahanS, BellamyCO, HarlandSN, HarrisonDJ, ProstS (2008) TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status. BMC Cancer 8: 191.
72. SongHL, LvS, LiuP (2009) The roles of tumor necrosis factor-alpha in colon tight junction protein expression and intestinal mucosa structure in a mouse model of acute liver failure. BMC Gastroenterol 9: 70.
73. KawaiY, HamazakiY, FujitaH, FujitaA, SatoT, et al. (2011) Claudin-4 induction by E-protein activity in later stages of CD4/8 double-positive thymocytes to increase positive selection efficiency. Proceedings of the National Academy of Sciences of the United States of America 108: 4075–4080.